Cleared Traditional

K121305 - STERLING MEDICAL IMPULSE 3 STIMULATOR

K121305 is an FDA 510(k) clearance for STERLING MEDICAL IMPULSE 3 STIMULATOR, manufactured by Armstrong Industries, Inc. Dha Mediquip Int. Dha S. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 147-day FDA review.

K121305 · Armstrong Industries, Inc. Dha Mediquip Int. Dha S · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2012
Decision
147d
Days
Class 2
Risk

K121305 is an FDA 510(k) clearance for the STERLING MEDICAL IMPULSE 3 STIMULATOR. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Armstrong Industries, Inc. Dha Mediquip Int. Dha S (Mckinney, US). The FDA issued a Cleared decision on September 25, 2012 after a review of 147 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Armstrong Industries, Inc. Dha Mediquip Int. Dha S devices

FDA 510(k) Submission Details - K121305

510(k) Number K121305 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 01, 2012
Decision Date September 25, 2012
Days to Decision 147 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 148d · This submission: 147d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 175
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K121305.
TENS device-EmeTerm, CinvStop
K172478 · Wat Medical Technology (Ningbo) Co., Ltd. · Apr 2018
WELL LIFE Rx Wireless TENS/EMS Stimulator, model WR-2603/2603A, WR-2604/2604A and WR-2605/2605A
K162663 · Well-Life Healthcare Limited · Jan 2017
SENSUS
K130919 · Neurometrix, Inc. · Jul 2013
SENSUS
K121184 · Neurometrix, Inc. · Aug 2012
NEUROTECH PLUS
K112258 · Bio-Medical Research, Ltd. · Jan 2012
KNEEHAB XP
K110350 · Bio-Medical Research, Ltd. · Aug 2011